{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:26:45Z","timestamp":1788449205426,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Taishan Scholar Youth Expert Program of Shandong Province","award":["tsqn202312349"],"award-info":[{"award-number":["tsqn202312349"]}]},{"name":"the Key Talent Program of Shandong First Medical University"},{"name":"the Health Development Promotion Project - Spark Research Program","award":["XHJH-0026"],"award-info":[{"award-number":["XHJH-0026"]}]},{"name":"the Clinical Medicine Innovation Program of Jinan City","award":["202328070"],"award-info":[{"award-number":["202328070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"DOI":"10.1186\/s41043-025-01113-9","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:15:43Z","timestamp":1761653743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diseases burden and trends of bladder cancer attributable to behavioral and metabolic factors among global and Chinese population, 1990\u20132021: results from the global burden of disease study 2021"],"prefix":"10.1186","volume":"44","author":[{"given":"Feifan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqiu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaju","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"1113_CR1","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"issue":"4","key":"1113_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/CU9.0000000000000219","volume":"17","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Sun X, Song X, Li Z, Zhang P, Zhang W, et al. Patient-derived bladder cancer organoid model to predict sensitivity and feasibility of tailored precision therapy. Curr Urol. 2023;17(4):221\u20138.","journal-title":"Curr Urol"},{"issue":"3","key":"1113_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1113_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"1113_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comp\u00e9rat E, Kamat AM, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84(2):176\u201390.","journal-title":"Eur Urol"},{"key":"1113_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-004128","author":"S Safiri","year":"2021","unstructured":"Safiri S, Kolahi AA, Naghavi M. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease study 2019. BMJ Glob Health. 2021. https:\/\/doi.org\/10.1136\/bmjgh-2020-004128.","journal-title":"BMJ Glob Health"},{"issue":"10292","key":"1113_CR7","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/S0140-6736(21)01169-7","volume":"397","author":"Spatial","year":"2021","unstructured":"Spatial. temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990\u20132019: a systematic analysis from the global burden of disease study 2019. Lancet. 2021;397(10292):2337\u201360.","journal-title":"Lancet"},{"issue":"5","key":"1113_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20(5):287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1113_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/pro6.1215","volume":"8","author":"W Wang","year":"2024","unstructured":"Wang W, Zhang F, Yuan S. Clinical guidelines for the prevention and treatment of radiation-induced bladder injury. Precis Radiat Oncol. 2024;8(1):4\u201313.","journal-title":"Precis Radiat Oncol"},{"issue":"10","key":"1113_CR10","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1021\/acs.chemrestox.2c00153","volume":"35","author":"M Bellamri","year":"2022","unstructured":"Bellamri M, Walmsley SJ, Brown C, Brandt K, Konorev D, Day A, et al. DNA damage and oxidative stress of tobacco smoke condensate in human bladder epithelial cells. Chem Res Toxicol. 2022;35(10):1863\u201380.","journal-title":"Chem Res Toxicol"},{"key":"1113_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1498207","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang J, He J, Lu Y, Lan T. Global disease burden of breast cancer attributable to high fasting plasma glucose: a comprehensive analysis from the global burden of disease study. Front Endocrinol (Lausanne). 2025;16:1498207.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1113_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.70006","author":"J Chen","year":"2025","unstructured":"Chen J, Zeng W, Dai D, Tang Y, Dong Y, Zhong Z, et al. A systematic analysis and prediction of the disease burden of ischemic heart disease caused by hyperglycemia. J Diabetes Investig. 2025. https:\/\/doi.org\/10.1111\/jdi.70006.","journal-title":"J Diabetes Investig"},{"issue":"1","key":"1113_CR13","doi-asserted-by":"publisher","first-page":"19017","DOI":"10.1038\/s41598-025-01357-9","volume":"15","author":"M Ma","year":"2025","unstructured":"Ma M, Wang S, Wang K, Jiang B, Li J, Hou S. CXCL12 links bladder cancer and diabetes as a potential biomarker. Sci Rep. 2025;15(1):19017.","journal-title":"Sci Rep"},{"key":"1113_CR14","doi-asserted-by":"crossref","unstructured":"Ramteke P, Deb A, Shepal V, Bhat MK. Hyperglycemia associated metabolic and molecular alterations in cancer Risk, Progression, Treatment, and mortality. Cancers (Basel). 2019;11(9).","DOI":"10.3390\/cancers11091402"},{"key":"1113_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.996440","volume":"12","author":"S Fang","year":"2022","unstructured":"Fang S, Liu Y, Dai H, Gao T, Zeng L, Sun R, et al. Association of metabolic syndrome and the risk of bladder cancer: a prospective cohort study. Front Oncol. 2022;12:996440.","journal-title":"Front Oncol"},{"key":"1113_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.699732","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu Y, Tao J. Diabetes mellitus and obesity as risk factors for bladder cancer prognosis: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2021;12:699732.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"1113_CR17","doi-asserted-by":"publisher","DOI":"10.1289\/EHP5496","volume":"127","author":"RM Shaffer","year":"2019","unstructured":"Shaffer RM, Sellers SP, Baker MG, de Buen Kalman R, Frostad J, Suter MK, et al. Improving and expanding estimates of the global burden of disease due to environmental health risk factors. Environ Health Perspect. 2019;127(10):105001.","journal-title":"Environ Health Perspect"},{"issue":"10440","key":"1113_CR18","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"Global burden and strength of evidence for","year":"2024","unstructured":"Global burden and strength of evidence for. 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2162\u2013203.","journal-title":"Lancet"},{"issue":"1","key":"1113_CR19","doi-asserted-by":"publisher","first-page":"7655","DOI":"10.1038\/s41598-025-92033-5","volume":"15","author":"X Su","year":"2025","unstructured":"Su X, Tao Y, Chen F, Han X, Xue L. Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the global burden of disease study 2021. Sci Rep. 2025;15(1):7655.","journal-title":"Sci Rep"},{"key":"1113_CR20","doi-asserted-by":"publisher","DOI":"10.18332\/tid\/204744","author":"Q Yu","year":"2025","unstructured":"Yu Q, Li B, Lin H, Sun C, Yang X, Zhang Z. Smoking-related bladder cancer burden from 1990 to 2021: an age-period-cohort analysis of the global burden of disease study. Tob Induc Dis. 2025. https:\/\/doi.org\/10.18332\/tid\/204744.","journal-title":"Tob Induc Dis"},{"issue":"15","key":"1113_CR21","doi-asserted-by":"publisher","first-page":"16469","DOI":"10.1002\/cam4.6219","volume":"12","author":"Y Wu","year":"2023","unstructured":"Wu Y, Deng Y, Dai Z, Ma Y, Lyu L, Lei C, et al. Estimates of bladder cancer burden attributable to high fasting plasma glucose: findings of the global burden of disease study 2019. Cancer Med. 2023;12(15):16469\u201381.","journal-title":"Cancer Med"},{"issue":"10440","key":"1113_CR22","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Global incidence","year":"2024","unstructured":"Global incidence. prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"issue":"10440","key":"1113_CR23","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"Global age-sex","year":"2024","unstructured":"Global age-sex. -specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):1989\u20132056.","journal-title":"Lancet"},{"issue":"6","key":"1113_CR24","doi-asserted-by":"publisher","first-page":"e0325937","DOI":"10.1371\/journal.pone.0325937","volume":"20","author":"C Hu","year":"2025","unstructured":"Hu C, Chen W, Zhang P, Shen T, Xu M. Global, regional, and national burden of leukemia: epidemiological trends analysis from 1990 to 2021. PLoS ONE. 2025;20(6):e0325937.","journal-title":"PLoS ONE"},{"issue":"5","key":"1113_CR25","doi-asserted-by":"publisher","first-page":"e0324039","DOI":"10.1371\/journal.pone.0324039","volume":"20","author":"JS Alqahtani","year":"2025","unstructured":"Alqahtani JS, AlDraiwiesh IA, Aldhahir AM, Oyelade T. Burden of smoking-related stroke in Saudi Arabia: trends from 1990 to 2021. PLoS ONE. 2025;20(5):e0324039.","journal-title":"PLoS ONE"},{"issue":"1","key":"1113_CR26","volume":"11","author":"H Zi","year":"2024","unstructured":"Zi H, Liu MY, Luo LS, Huang Q, Luo PC, Luan HH, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024;11(1):64.","journal-title":"Mil Med Res"},{"key":"1113_CR27","doi-asserted-by":"publisher","first-page":"1561052","DOI":"10.3389\/fcvm.2025.1561052","volume":"12","author":"Q Liu","year":"2025","unstructured":"Liu Q, Su J, Liang Y, He X. Global burden and trend of stroke attributable to metabolic risks among young adults (20\u201339 years old) from 1990 to 2021. Front Cardiovasc Med. 2025;12:1561052.","journal-title":"Front Cardiovasc Med"},{"key":"1113_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1490428","volume":"16","author":"Z Sun","year":"2025","unstructured":"Sun Z, Zhang M, Zuo Y, Li W, Li S, Zhang Y, et al. The persistent challenge of ischemic stroke burden from high fasting plasma glucose: a global perspective. Front Endocrinol (Lausanne). 2025;16:1490428.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1113_CR29","unstructured":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017., et al. Lancet. 2018;392(10159):1923\u201394."},{"key":"1113_CR30","doi-asserted-by":"crossref","unstructured":"Wang R, Zhang Z, Shan X, Dong J, Yang X, Zhang J et al. Tobacco-related lung cancer burden in the Western Pacific region from 1990 to 2021: an age-period-cohort analysis from the global burden of disease study. Tob Induc Dis. 2025;23.","DOI":"10.18332\/tid\/201970"},{"issue":"4","key":"1113_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/CU9.0000000000000193","volume":"17","author":"Y Iemura","year":"2023","unstructured":"Iemura Y, Miyake M, Fukui S, Fujii T, Ohnishi S, Hori S, et al. Depth of invasion to the bladder wall as a prognostic factor and its association with circulating cell-free DNA levels in patients with muscle-invasive bladder cancer. Curr Urol. 2023;17(4):229\u201335.","journal-title":"Curr Urol"},{"issue":"1","key":"1113_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96\u2013108.","journal-title":"Eur Urol"},{"issue":"1","key":"1113_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/jamainternmed.2016.7511","volume":"177","author":"M Inoue-Choi","year":"2017","unstructured":"Inoue-Choi M, Liao LM, Reyes-Guzman C, Hartge P, Caporaso N, Freedman ND. Association of long-term, low-intensity smoking with all-cause and cause-specific mortality in the National Institutes of Health-AARP diet and health study. JAMA Intern Med. 2017;177(1):87\u201395.","journal-title":"JAMA Intern Med"},{"key":"1113_CR34","volume":"24","author":"Z Liu","year":"2022","unstructured":"Liu Z, Li YH, Cui ZY, Li L, Nie XQ, Yu CD, et al. Prevalence of tobacco dependence and associated factors in China: findings from nationwide China health literacy survey during 2018-19. The Lancet Regional Health. 2022;24:100464.","journal-title":"The Lancet Regional Health"},{"issue":"1","key":"1113_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S2213-2600(18)30432-6","volume":"7","author":"M Wang","year":"2019","unstructured":"Wang M, Luo X, Xu S, Liu W, Ding F, Zhang X, et al. Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013. Lancet Respir Med. 2019;7(1):35\u201345.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"1113_CR36","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s12276-023-00997-z","volume":"55","author":"B Yan","year":"2023","unstructured":"Yan B, Li X, Peng M, Zuo Y, Wang Y, Liu P, et al. The YTHDC1\/GLUT3\/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression. Exp Mol Med. 2023;55(6):1145\u201358.","journal-title":"Exp Mol Med"},{"key":"1113_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2025.101381","volume":"104","author":"L da Cunha Agostini","year":"2025","unstructured":"da Cunha Agostini L, da Silva GN. Type 2 diabetes mellitus and bladder cancer: a narrative review on associated signaling pathways. Mol Aspects Med. 2025;104:101381.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"1113_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2337\/dc16-1075","volume":"40","author":"M Moradi-Lakeh","year":"2017","unstructured":"Moradi-Lakeh M, Forouzanfar MH, El Bcheraoui C, Daoud F, Afshin A, Hanson SW, et al. High fasting plasma glucose, diabetes, and its risk factors in the Eastern Mediterranean Region, 1990\u20132013: findings from the global burden of disease study 2013. Diabetes Care. 2017;40(1):22\u20139.","journal-title":"Diabetes Care"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-025-01113-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:15:48Z","timestamp":1761653748000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhpn.biomedcentral.com\/articles\/10.1186\/s41043-025-01113-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1186\/s41043-025-01113-9","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"4 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The GBD 2021 study is a publicly available database and all data were anonymous. The study does not involve any ethical problem.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"377"}}